Don’t Get Addicted to Alkermes’ Low Revenue

Don’t Get Addicted to Alkermes’ Low Revenue
One FDA approval down, one more in the works.
Read more on The Motley Fool

Alkermes’ Vivitrol Wins New Approval
FDA approves Alkermes’ addiction drug Vivitrol as a new treatment for opioid addiction.
Read more on TheStreet.com

Subscribe to Our Feed!

Enter your email address:

Delivered by FeedBurner